TrialDiabetes2021

SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans.

Harunobu Nishizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.